Exploring the potential benefits of combining cannabidiol and beta-caryophyllene for neuropathic and inflammatory pain: A systematic review
Phytomedicine · 2026-11 · 162 · 158798
DOI: 10.1016/j.phymed.2026.158798 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Phytomedicine, 2026-11. Verfasst von Khalid Benamar. Beteiligte Einrichtung: Institute of Neuroscience and Department of Neuro-behavioral Health, University of Texas Rio Grande Valley, School of Medicine, Biomedical Building, …. Hauptthemen laut MEDLINE: Polycyclic Sesquiterpenes, Cannabidiol, Neuralgia, Analgesics. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, National Institute on Drug Abuse Intramural Research Program, National Institute of Development Administration.
Abstract (Originalsprache)
PURPOSE: In this review, we examined the analgesic effect of the combination of cannabidiol (CBD) and beta-caryophyllene (BCP) in different pain conditions. METHODS: A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Literature searches were performed across major academic databases (Google Scholar, Web of Science, and PubMed) from 2009 to 2026 to identify studies investigating the analgesic effect of the combination of CBD and BCP. RESULTS: The search identified 31 records. Ten reports were screened and assessed for eligibility, and five studies met the inclusion and exclusion criteria. Findings consistently demonstrate that the combination of CBD and BCP reduces neuropathic and inflammatory pain in rodent models. This effect does not result in adverse outcomes associated with cannabinoid receptor 1 (CB1). This review discusses potential mechanisms by which this combination produces synergistic analgesic effects. CONCLUSION: The literature discussed in this review suggests that the combination of CBD and BCP can work in synergy in chronic pain without cannabinoid receptor 1 central side effects. These preclinical findings provide the rationale for future preclinical and clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Neuroscience and Department of Neuro-behavioral Health, University of Texas Rio Grande Valley, School of Medicine, Biomedical Building, McAllen, TX, 78504, USA. Electronic address: khalid.benamar@utrgv.edu.
Förderung
- National Institutes of Health
- National Institute on Drug Abuse Intramural Research Program
- National Institute of Development Administration
Zitieren
APA
Benamar, K. (2026). Exploring the potential benefits of combining cannabidiol and beta-caryophyllene for neuropathic and inflammatory pain: A systematic review. Phytomedicine, 162, 158798. https://doi.org/10.1016/j.phymed.2026.158798
Vancouver
Benamar K. Exploring the potential benefits of combining cannabidiol and beta-caryophyllene for neuropathic and inflammatory pain: A systematic review. Phytomedicine. 2026;162:158798. doi:10.1016/j.phymed.2026.158798
BibTeX
@article{Benamar2026,
author = {Benamar, Khalid},
title = {Exploring the potential benefits of combining cannabidiol and beta-caryophyllene for neuropathic and inflammatory pain: A systematic review},
journal = {Phytomedicine},
year = {2026},
volume = {162},
pages = {158798},
doi = {10.1016/j.phymed.2026.158798}
}
EUVIMED